RU2021121514A - METHOD FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 IN HUMANS WITH MEDICATIONS WITH A NEW PURPOSE - Google Patents

METHOD FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 IN HUMANS WITH MEDICATIONS WITH A NEW PURPOSE Download PDF

Info

Publication number
RU2021121514A
RU2021121514A RU2021121514A RU2021121514A RU2021121514A RU 2021121514 A RU2021121514 A RU 2021121514A RU 2021121514 A RU2021121514 A RU 2021121514A RU 2021121514 A RU2021121514 A RU 2021121514A RU 2021121514 A RU2021121514 A RU 2021121514A
Authority
RU
Russia
Prior art keywords
treatment
medications
humans
covid
coronavirus infection
Prior art date
Application number
RU2021121514A
Other languages
Russian (ru)
Inventor
Сергей Юрьевич Родионов
Original Assignee
Сергей Юрьевич Родионов
Filing date
Publication date
Application filed by Сергей Юрьевич Родионов filed Critical Сергей Юрьевич Родионов
Publication of RU2021121514A publication Critical patent/RU2021121514A/en

Links

Claims (3)

1. Применение гексаметилентетрамина для лечения короновирусной инфекции COVID-19 и вызванных ею осложнений.1. The use of hexamethylenetetramine for the treatment of COVID-19 coronovirus infection and its complications. 2. Способ лечения короновирусной инфекции человека COVID-19 и вызванных ею осложнений, при котором пациенту вводят гексаметилентетрамин перорально 0,5-1,0 г на прием, 3-4 раза в сутки 7-14 дней или внутривенно 7-10 дней.2. A method for the treatment of human coronovirus infection COVID-19 and its complications, in which the patient is administered hexamethylenetetramine orally 0.5-1.0 g per dose, 3-4 times a day for 7-14 days or intravenously for 7-10 days. 3. Способ по п. 2, отличающийся тем, что для усиления противовирусной активности гексаметилентетрамин предварительно растворяют в изотонических растворах с кислой средой рН<7, а затем вводят в организм человека внутрь перорально или парентерально.3. The method according to claim 2, characterized in that to enhance the antiviral activity, hexamethylenetetramine is preliminarily dissolved in isotonic solutions with an acidic pH <7, and then administered orally or parenterally to the human body.
RU2021121514A 2021-07-20 METHOD FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 IN HUMANS WITH MEDICATIONS WITH A NEW PURPOSE RU2021121514A (en)

Publications (1)

Publication Number Publication Date
RU2021121514A true RU2021121514A (en) 2023-01-20

Family

ID=

Similar Documents

Publication Publication Date Title
RU2021121514A (en) METHOD FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 IN HUMANS WITH MEDICATIONS WITH A NEW PURPOSE
Hodgson et al. Effects of pentoxifylline on experimental skin flap survival
RU2721876C1 (en) Method for etiopathogenetic treatment of influenza patients
RU2009128724A (en) APPLICATION OF A COMPOSITION OF LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLYCAN OF GRAM-NEGATIVE BACTERIA FOR THE TREATMENT AND PREVENTION OF HUMAN DISEASES
WO2022019742A1 (en) Pharmaceutical package for preventing and/or treating covid-19 disease and use of same
RU2370264C2 (en) Method of organism disintoxication in surgery of locally advanced hypernephroid cancer
RU2284825C1 (en) Method for treating abscesses, soft tissue phlegmons
RU2585097C1 (en) Method of treating chronic pancreatitis
RU2742341C1 (en) Method for treating chronic generalized periodontitis
RU2013148539A (en) ALISPORIVIR FOR TREATMENT OF HEPATITIS C VIRUS INFECTION
Hill et al. Experimental Studies with Mercurials in Experimental Syphilis: With a Brief Note on Their Clinical Application, Especially as to Flumerin
US6479547B1 (en) Method of treating an infection by enhancing the effectiveness of the human immune system
RU2530587C1 (en) Method of treating skin and mucosal diseases caused by herpes simplex viruses type 1 and type 2
RU2128531C1 (en) Method of treatment of children&#39;s gastroenterologic diseases
RU2196590C1 (en) Agent carbon-mercury hydrosulfate complex and method of treatment of infectious inflammatory sicknesses
UA75078U (en) method for conservative treatment of chronic prostatitis, complicated with calculus in the prostate gland
RU2483766C2 (en) Method of treating herpetic stomatitis in hiv-patients
RU2358745C1 (en) Scalp seborrhoea therapy
TR201700665A2 (en) The composition of a drug for use in the treatment of acute and chronic sinusitis
RU2517053C1 (en) Method of treatment of animals with surgical sepsis
RU2128052C1 (en) Method of treatment of patients with chronic prostatitis
UA120398U (en) METHOD OF TREATMENT OF RECURRENT HIV-ASSOCIATED GENITAL HERPES
RU2021100008A (en) A method for the prevention of acute respiratory diseases, acute respiratory viral infections with the help of the drug Artemisia bitter herb
RU2071773C1 (en) Medicinal agent for treatment of acquired immunodeficiency syndromes, among them hiv-depended
RU2289456C1 (en) Method for treatment of hemorrhagic fever with renal syndrome of averagely severe and severe forms